COVID-19 Impact on Sleeping Aids Market, Global Research Reports 2020-2021

SKU ID :QYR-15683869 | Published Date: 20-May-2020 | No. of pages: 104
1.1 Research Scope 1.2 Market Segmentation 1.3 Research Objectives 1.4 Research Methodology 1.4.1 Research Process 1.4.2 Data Triangulation 1.4.3 Research Approach 1.4.4 Base Year 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.5.2 Covid-19 Impact: Commodity Prices Indices 1.5.3 Covid-19 Impact: Global Major Government Policy 1.6 The Covid-19 Impact on Sleeping Aids Industry 1.7 COVID-19 Impact: Sleeping Aids Market Trends 2 Global Sleeping Aids Quarterly Market Size Analysis 2.1 Sleeping Aids Business Impact Assessment - COVID-19 2.1.1 Global Sleeping Aids Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.1.2 Global Sleeping Aids Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.2 Global Sleeping Aids Quarterly Market Size 2020-2021 2.3 COVID-19-Driven Market Dynamics and Factor Analysis 2.3.1 Drivers 2.3.2 Restraints 2.3.3 Opportunities 2.3.4 Challenges 3 Quarterly Competitive Assessment, 2020 3.1 Global Sleeping Aids Quarterly Market Size by Manufacturers, 2019 VS 2020 3.2 Global Sleeping Aids Factory Price by Manufacturers 3.3 Location of Key Manufacturers Sleeping Aids Manufacturing Factories and Area Served 3.4 Date of Key Manufacturers Enter into Sleeping Aids Market 3.5 Key Manufacturers Sleeping Aids Product Offered 3.6 Mergers & Acquisitions, Expansion Plans 4 Impact of Covid-19 on Sleeping Aids Segments, By Type 4.1 Introduction 1.4.1 Medication 1.4.2 Mattresses and Pillows 1.4.3 Sleep Apnea Devices 1.4.4 Other 4.2 By Type, Global Sleeping Aids Market Size, 2019-2021 4.2.1 By Type, Global Sleeping Aids Market Size by Type, 2020-2021 4.2.2 By Type, Global Sleeping Aids Price, 2020-2021 5 Impact of Covid-19 on Sleeping Aids Segments, By Application 5.1 Overview 5.5.1 Insomnia 5.5.2 Restless Legs Syndrome 5.5.3 Sleep Apnea 5.5.4 Narcolepsy 5.5.5 Sleep Walking 5.5.6 Other 5.2 By Application, Global Sleeping Aids Market Size, 2019-2021 5.2.1 By Application, Global Sleeping Aids Market Size by Application, 2019-2021 5.2.2 By Application, Global Sleeping Aids Price, 2020-2021 6 Geographic Analysis 6.1 Introduction 6.2 North America 6.2.1 Macroeconomic Indicators of US 6.2.2 US 6.2.3 Canada 6.3 Europe 6.3.1 Macroeconomic Indicators of Europe 6.3.2 Germany 6.3.3 France 6.3.4 UK 6.3.5 Italy 6.4 Asia-Pacific 6.4.1 Macroeconomic Indicators of Asia-Pacific 6.4.2 China 6.4.3 Japan 6.4.4 South Korea 6.4.5 India 6.4.6 ASEAN 6.5 Rest of World 6.5.1 Latin America 6.5.2 Middle East and Africa 7 Company Profiles 7.1 GlaxoSmithKline 7.1.1 GlaxoSmithKline Business Overview 7.1.2 GlaxoSmithKline Sleeping Aids Quarterly Production and Revenue, 2020 7.1.3 GlaxoSmithKline Sleeping Aids Product Introduction 7.1.4 GlaxoSmithKline Response to COVID-19 and Related Developments 7.2 Pfizer 7.2.1 Pfizer Business Overview 7.2.2 Pfizer Sleeping Aids Quarterly Production and Revenue, 2020 7.2.3 Pfizer Sleeping Aids Product Introduction 7.2.4 Pfizer Response to COVID-19 and Related Developments 7.3 Merck 7.3.1 Merck Business Overview 7.3.2 Merck Sleeping Aids Quarterly Production and Revenue, 2020 7.3.3 Merck Sleeping Aids Product Introduction 7.3.4 Merck Response to COVID-19 and Related Developments 7.4 Becton Dickinson 7.4.1 Becton Dickinson Business Overview 7.4.2 Becton Dickinson Sleeping Aids Quarterly Production and Revenue, 2020 7.4.3 Becton Dickinson Sleeping Aids Product Introduction 7.4.4 Becton Dickinson Response to COVID-19 and Related Developments 7.5 Hill-Rom 7.5.1 Hill-Rom Business Overview 7.5.2 Hill-Rom Sleeping Aids Quarterly Production and Revenue, 2020 7.5.3 Hill-Rom Sleeping Aids Product Introduction 7.5.4 Hill-Rom Response to COVID-19 and Related Developments 7.6 Koninklijke Philips 7.6.1 Koninklijke Philips Business Overview 7.6.2 Koninklijke Philips Sleeping Aids Quarterly Production and Revenue, 2020 7.6.3 Koninklijke Philips Sleeping Aids Product Introduction 7.6.4 Koninklijke Philips Response to COVID-19 and Related Developments 7.7 Teva Pharmaceuticals 7.7.1 Teva Pharmaceuticals Business Overview 7.7.2 Teva Pharmaceuticals Sleeping Aids Quarterly Production and Revenue, 2020 7.7.3 Teva Pharmaceuticals Sleeping Aids Product Introduction 7.7.4 Teva Pharmaceuticals Response to COVID-19 and Related Developments 7.8 Abecca Healthcare 7.8.1 Abecca Healthcare Business Overview 7.8.2 Abecca Healthcare Sleeping Aids Quarterly Production and Revenue, 2020 7.8.3 Abecca Healthcare Sleeping Aids Product Introduction 7.8.4 Abecca Healthcare Response to COVID-19 and Related Developments 7.9 Betterlifehealthcare 7.9.1 Betterlifehealthcare Business Overview 7.9.2 Betterlifehealthcare Sleeping Aids Quarterly Production and Revenue, 2020 7.9.3 Betterlifehealthcare Sleeping Aids Product Introduction 7.9.4 Betterlifehealthcare Response to COVID-19 and Related Developments 7.10 Cadwell Laboratories 7.10.1 Cadwell Laboratories Business Overview 7.10.2 Cadwell Laboratories Sleeping Aids Quarterly Production and Revenue, 2020 7.10.3 Cadwell Laboratories Sleeping Aids Product Introduction 7.10.4 Cadwell Laboratories Response to COVID-19 and Related Developments 7.11 Compumedics 7.11.1 Compumedics Business Overview 7.11.2 Compumedics Sleeping Aids Quarterly Production and Revenue, 2020 7.11.3 Compumedics Sleeping Aids Product Introduction 7.11.4 Compumedics Response to COVID-19 and Related Developments 7.12 Lifeline Corporation 7.12.1 Lifeline Corporation Business Overview 7.12.2 Lifeline Corporation Sleeping Aids Quarterly Production and Revenue, 2020 7.12.3 Lifeline Corporation Sleeping Aids Product Introduction 7.12.4 Lifeline Corporation Response to COVID-19 and Related Developments 7.13 Medical Depot 7.13.1 Medical Depot Business Overview 7.13.2 Medical Depot Sleeping Aids Quarterly Production and Revenue, 2020 7.13.3 Medical Depot Sleeping Aids Product Introduction 7.13.4 Medical Depot Response to COVID-19 and Related Developments 7.14 Natus Medical 7.14.1 Natus Medical Business Overview 7.14.2 Natus Medical Sleeping Aids Quarterly Production and Revenue, 2020 7.14.3 Natus Medical Sleeping Aids Product Introduction 7.14.4 Natus Medical Response to COVID-19 and Related Developments 7.15 Talley Group 7.15.1 Talley Group Business Overview 7.15.2 Talley Group Sleeping Aids Quarterly Production and Revenue, 2020 7.15.3 Talley Group Sleeping Aids Product Introduction 7.15.4 Talley Group Response to COVID-19 and Related Developments 8 Supply Chain and Sales Channels Analysis 8.1 Sleeping Aids Supply Chain Analysis 8.1.1 Sleeping Aids Supply Chain Analysis 8.1.2 Covid-19 Impact on Sleeping Aids Supply Chain 8.2 Distribution Channels Analysis 8.2.1 Sleeping Aids Distribution Channels 8.2.2 Covid-19 Impact on Sleeping Aids Distribution Channels 8.2.3 Sleeping Aids Distributors 8.3 Sleeping Aids Customers 9 Key Findings 10 Appendix 10.1 About Us 10.2 Disclaimer
List of Tables Table 1. Overview of the World Economic Outlook Projections Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity) Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 7. Covid-19 Impact: Global Major Government Policy Table 8. The Covid-19 Impact on Sleeping Aids Assessment Table 9. COVID-19 Impact: Sleeping Aids Market Trends Table 10. COVID-19 Impact Global Sleeping Aids Market Size Table 11. Global Sleeping Aids Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units) Table 12. Global Sleeping Aids Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit) Table 13. Global Sleeping Aids Quarterly Market Size, 2020 (US$ Million) & (K Units) Table 14. Global Sleeping Aids Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million) Table 15. Global Sleeping Aids Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units) Table 16. Global Sleeping Aids Market Growth Drivers Table 17. Global Sleeping Aids Market Restraints Table 18. Global Sleeping Aids Market Opportunities Table 19. Global Sleeping Aids Market Challenges Table 20. Key Manufacturers Sleeping Aids Quarterly Revenue, 2019 VS 2020 (US$ Million) Table 21. Top Manufacturers, Sleeping Aids Market Size, 2019 (K Units) & (US$ Million) Table 22. Sleeping Aids Factory Price by Manufacturers 2020 (USD/Unit) Table 23. Location of Key Manufacturers Sleeping Aids Manufacturing Plants Table 24. Key Manufacturers Sleeping Aids Market Served Table 25. Date of Key Manufacturers Enter into Sleeping Aids Market Table 26. Key Manufacturers Sleeping Aids Product Type Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Sleeping Aids Market Size by Type, 2020, (US$ Million) Table 29. Global Sleeping Aids Market Size by Type, 2020 (K Units) Table 30. Global Sleeping Aids Price: by Type, 2020-2021 (USD/Unit) Table 31. Global Sleeping Aids Market Size by Application: 2020-2021 (US$ Million) Table 32. Global Sleeping Aids Market Size by Application, 2020-2021 (K Units) Table 33. Global Sleeping Aids Price: by Application, 2020-2021 (USD/Unit) Table 34. Global Sleeping Aids Market Size by Region, 2019-2021 (US$ Million) Table 35. Global Sleeping Aids Market Size by Region, 2019-2021 (K Units) Table 36. By Country, North America Sleeping Aids Market Size, 2019-2021 (US$ Million) Table 37. By Country, North America Sleeping Aids Market Size, 2019-2021 (K Units) Table 38. US Sleeping Aids Market Size, 2019-2021 (US$ Million) & (K Units) Table 39. Canada Sleeping Aids Market Size, 2019-2021 (US$ Million) & (K Units) Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy) Table 41. By Country, Europe Sleeping Aids Market Size, 2019-2021 (US$ Million) Table 42. By Country, Europe Sleeping Aids Market Size, 2019-2021 (K Units) Table 43. Germany Sleeping Aids Market Size, 2019-2021 (US$ Million) & (K Units) Table 44. France Sleeping Aids Market Size, 2019-2021 (US$ Million) & (K Units) Table 45. UK Sleeping Aids Market Size, 2019-2021 (US$ Million) & (K Units) Table 46. Italy Sleeping Aids Market Size, 2019-2021 (US$ Million) & (K Units) Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN) Table 48. By Region, Asia-Pacific Sleeping Aids Market Size, 2019-2021 (US$ Million) Table 49. By Region, Asia-Pacific Sleeping Aids Market Size, 2019-2021 (K Units) Table 50. China Sleeping Aids Market Size, 2019-2021 (US$ Million) & (K Units) Table 51. Japan Sleeping Aids Market Size, 2019-2021 (US$ Million) & (K Units) Table 52. South Korea Sleeping Aids Market Size, 2019-2021 (US$ Million) & (K Units) Table 53. India Sleeping Aids Market Size, 2019-2021 (US$ Million) & (K Units) Table 54. ASEAN Sleeping Aids Market Size, 2019-2021 (US$ Million) & (K Units) Table 55. Latin America Sleeping Aids Market Size, 2019-2021 (US$ Million) & (K Units) Table 56. Middle East and Africa Sleeping Aids Market Size, 2019-2021 (US$ Million) & (K Units) Table 57. GlaxoSmithKline Business Overview Table 58. GlaxoSmithKline Sleeping Aids Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 59. GlaxoSmithKline Sleeping Aids Product Table 60. GlaxoSmithKline Response to COVID-19 and Related Developments Table 61. Pfizer Business Overview Table 62. Pfizer Sleeping Aids Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 63. Pfizer Sleeping Aids Product Table 64. Pfizer Response to COVID-19 and Related Developments Table 65. Merck Business Overview Table 66. Merck Sleeping Aids Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 67. Merck Sleeping Aids Product Table 68. Merck Response to COVID-19 and Related Developments Table 69. Becton Dickinson Business Overview Table 70. Becton Dickinson Sleeping Aids Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 71. Becton Dickinson Sleeping Aids Product Table 72. Becton Dickinson Response to COVID-19 and Related Developments Table 73. Hill-Rom Business Overview Table 74. Hill-Rom Sleeping Aids Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 75. Hill-Rom Sleeping Aids Product Table 76. Hill-Rom Response to COVID-19 and Related Developments Table 77. Koninklijke Philips Business Overview Table 78. Koninklijke Philips Sleeping Aids Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 79. Koninklijke Philips Sleeping Aids Product Table 80. Koninklijke Philips Response to COVID-19 and Related Developments Table 81. Teva Pharmaceuticals Business Overview Table 82. Teva Pharmaceuticals Sleeping Aids Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 83. Teva Pharmaceuticals Sleeping Aids Product Table 84. Teva Pharmaceuticals Response to COVID-19 and Related Developments Table 85. Abecca Healthcare Business Overview Table 86. Abecca Healthcare Sleeping Aids Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 87. Abecca Healthcare Sleeping Aids Product Table 88. Abecca Healthcare Response to COVID-19 and Related Developments Table 89. Betterlifehealthcare Business Overview Table 90. Betterlifehealthcare Sleeping Aids Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 91. Betterlifehealthcare Sleeping Aids Product Table 92. Betterlifehealthcare Response to COVID-19 and Related Developments Table 93. Cadwell Laboratories Business Overview Table 94. Cadwell Laboratories Sleeping Aids Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 95. Cadwell Laboratories Sleeping Aids Product Table 96. Cadwell Laboratories Response to COVID-19 and Related Developments Table 97. Compumedics Business Overview Table 98. Compumedics Sleeping Aids Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 99. Compumedics Sleeping Aids Product Table 100. Compumedics Response to COVID-19 and Related Developments Table 101. Lifeline Corporation Business Overview Table 102. Lifeline Corporation Sleeping Aids Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 103. Lifeline Corporation Sleeping Aids Product Table 104. Lifeline Corporation Response to COVID-19 and Related Developments Table 105. Medical Depot Business Overview Table 106. Medical Depot Sleeping Aids Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 107. Medical Depot Sleeping Aids Product Table 108. Medical Depot Response to COVID-19 and Related Developments Table 109. Natus Medical Business Overview Table 110. Natus Medical Sleeping Aids Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 111. Natus Medical Sleeping Aids Product Table 112. Natus Medical Response to COVID-19 and Related Developments Table 113. Talley Group Business Overview Table 114. Talley Group Sleeping Aids Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 115. Talley Group Sleeping Aids Product Table 116. Talley Group Response to COVID-19 and Related Developments Table 117. Sleeping Aids Distributors List Table 118. Sleeping Aids Customers List Table 119. Covid-19 Impact on Sleeping Aids Customers List of Figures Figure 1. Sleeping Aids Product Picture Figure 2. Sleeping Aids Market Segmentation Figure 3. Research Objectives Figure 4. Research Process Figure 5. Data Triangulation Figure 6. Research Approach Figure 7. Commodity Prices-Metals Price Indices Figure 8. Commodity Prices- Precious Metal Price Indices Figure 9. Commodity Prices- Agricultural Raw Material Price Indices Figure 10. Commodity Prices- Food and Beverage Price Indices Figure 11. Commodity Prices- Fertilizer Price Indices Figure 12. Commodity Prices- Energy Price Indices Figure 13. G20+: Economic Policy Responses to COVID-19 Figure 14. Global Sleeping Aids Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million) Figure 15. Global Sleeping Aids Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%) Figure 16. Global Sleeping Aids Market Size, Quarterly Growth, 2020-2021 (%) Figure 17. Global Sleeping Aids Market Size, Market Share by Type, 2019 VS 2020 (%) Figure 18. Global Sleeping Aids Market Size, Market Share by Application, 2019 VS 2020 (%) Figure 19. Global Sleeping Aids Market Size Market Share by Region, 2019 VS 2020 (%) Figure 20. United States Composite PMI and GDP Figure 21. Eurozone Composite PMI and GDP Figure 22. Eurozone Core v. Periphery PMI Output Indices Figure 23. Core v. Periphery PMI Employment Indices Figure 24. UK Composite PMI and GDP Figure 25. Caixin China Composite Output Index Figure 26. Caixin China General Services Business Activity Index Figure 27. Japan Composite Output Index Figure 28. South Korea Manufacturing PMI Figure 29. India Composite Output Index Figure 30. ASEAN Manufacturing PMI Figure 31. By Region, Asia-Pacific Sleeping Aids Market Size Market Share, 2019-2021
GlaxoSmithKline Pfizer Merck Becton Dickinson Hill-Rom Koninklijke Philips Teva Pharmaceuticals Abecca Healthcare Betterlifehealthcare Cadwell Laboratories Compumedics Lifeline Corporation Medical Depot Natus Medical Talley Group
  • PRICE
  • $3250
    $6500
    Buy Now

Our Clients